Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression

被引:25
作者
Dower, Ken [1 ,2 ]
Rubins, Kathleen H. [2 ]
Hensley, Lisa E. [3 ]
Connor, John H. [1 ]
机构
[1] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA
[2] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[3] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA
关键词
Orthopoxvirus; Antiviral; Gene expression; High-throughput; Drug discovery; GREEN FLUORESCENT PROTEIN; TRANSCRIPTION ELONGATION-FACTOR; DNA-REPLICATION; MESSENGER-RNAS; MONKEYPOX; SMALLPOX; INTERMEDIATE; CELLS; GENERATION; SELECTION;
D O I
10.1016/j.antiviral.2011.04.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vaccinia virus is the prototypical orthopoxvirus of Poxviridae, a family of viruses that includes the human pathogens Variola (smallpox) and Monkeypox. Core viral functions are conserved among orthopoxviruses, and consequently Vaccinia is routinely used to study poxvirus biology and screen for novel antiviral compounds. Here we describe the development of a series of fluorescent protein-based reporter Vaccinia viruses that provide unprecedented resolution for tracking viral function. The reporter viruses are divided into two sets: (1) single reporter viruses that utilize temporally regulated early, intermediate, or late viral promoters; and (2) multi-reporter viruses that utilize multiple temporally regulated promoters. Promoter and reporter combinations were chosen that yielded high signal-to-background for stage-specific viral outputs. We provide examples for how these viruses can be used in the rapid and accurate monitoring of Vaccinia function and drug action. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 32 条
[1]   CHARACTERIZATION AND TEMPORAL REGULATION OF MESSENGER-RNAS ENCODED BY VACCINIA VIRUS INTERMEDIATE-STAGE GENES [J].
BALDICK, CJ ;
MOSS, B .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3515-3527
[2]   MUTATIONAL ANALYSIS OF THE CORE, SPACER, AND INITIATOR REGIONS OF VACCINIA VIRUS INTERMEDIATE-CLASS PROMOTERS [J].
BALDICK, CJ ;
KECK, JG ;
MOSS, B .
JOURNAL OF VIROLOGY, 1992, 66 (08) :4710-4719
[3]   VACCINIA VIRUS PRODUCES LATE MESSENGER-RNAS BY DISCONTINUOUS SYNTHESIS [J].
BERTHOLET, C ;
VAN MEIR, E ;
TENHEGGELERBORDIER, B ;
WITTEK, R .
CELL, 1987, 50 (02) :153-162
[4]   Phenotypic characterization of mutants in vaccinia virus gene G2R, a putative transcription elongation factor [J].
Black, EP ;
Condit, RC .
JOURNAL OF VIROLOGY, 1996, 70 (01) :47-54
[5]   Vaccinia virus transcription [J].
Broyles, SS .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2293-2303
[6]  
BROYLES SS, 1991, J BIOL CHEM, V266, P15539
[7]   Attenuation of green fluorescent protein half-life in mammalian cells [J].
Corish, P ;
Tyler-Smith, C .
PROTEIN ENGINEERING, 1999, 12 (12) :1035-1040
[8]   Brief report: Tanapox infection in a college student [J].
Dhar, AD ;
Werchniak, AE ;
Li, Y ;
Brennick, JB ;
Goldsmith, CS ;
Kline, R ;
Damon, I ;
Klaus, SN .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :361-366
[9]   Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox [J].
Hammarlund, E ;
Lewis, MW ;
Carter, SV ;
Amanna, I ;
Hansen, SG ;
Strelow, LI ;
Wong, SW ;
Yoshihara, P ;
Hanifin, JM ;
Slifka, MK .
NATURE MEDICINE, 2005, 11 (09) :1005-1011
[10]   Duration of antiviral immunity after smallpox vaccination [J].
Hammarlund, E ;
Lewis, MW ;
Hansen, SG ;
Strelow, LI ;
Nelson, JA ;
Sexton, GJ ;
Hanifin, JM ;
Slifka, MK .
NATURE MEDICINE, 2003, 9 (09) :1131-1137